| http://www.w3.org/ns/prov#value | - Generic revenues in our Rest of the World market amounted to $620 million, a decrease of 11%, or 8% in local currency terms, compared to the third quarter of 2011 with strong performance in Israel, Russia and other Eastern European markets, which was negatively offset by decrease in generic sales in Canada, where we had exceptionally high revenues in the third quarter of 2011 in the comparison.
|
